Skip to search formSkip to main contentSkip to account menu

5-methyl-8-hydroxyquinoline

Known as: 5-methyloxine, Tiliquinol, 5-Methylquinolin-8-ol 
An antiprotozoal agent that was used in combination with tibroquinol. The combination agent was withdrawn from the market because of hepatoxicity.
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Oxyquinoline
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
[Acute hepatitis caused by the combination of tiliquinol and tilbroquinol (Intétrix)].
1996
1996
Hépatite aiguë due à l'association de tiliquinol et tilbroquinol (Intétrix).
1994
1994
[In vitro sensitivity of Vibrio cholerae serotype 0:139 to an intestinal antiseptic tiliquinol-tilbroquinol combination].
O:139 is a new serotype of Vibrio cholerae that is not agglutinated by an O:1 antiserum but causes epidemics of cholera. Strains… 
1992
1992
[Resistance of Vibrio cholerae 0:1 to the 0/129 compound and multiresistance to antibiotics].
The authors present a study of the in vitro susceptibility to O/129 compound and usual antibiotics of 29 strains of V. cholerae O… 
1985
1985
Neuropathie et atteinte oculaire après utilisation prolongée de tilbroquinol et de tiliquinol
1985
1985
[Neuropathy and ocular involvement following prolonged use of tilbroquinol and tiliquinol].
1975
1975
[Effect of the combination of 5-methylquinolin-8-ol, 7-bromo-5-methylquinolin-8-ol and 5-methylquinolin-8-ol-dodecylsulfate on the intestinal flora of healthy subjects].
The influence of a combination of 5-methyl-quinolin-8-ol, 7-bromo-5-methyl-quinolin-8-ol with 5-methyl-quinolin-8-ol… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)